CRENESSITY
Live / Registered — Registered (as of 27 May 2025)
What this means for you
Registered since 27 May 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97028747
- Registration number
- 7811758
- Mark type
- Stylized text
- Filed
- 15 Sept 2021
- Published for opposition
- 06 Dec 2022
- Registered
- 27 May 2025
- Attorney of record
- Allison Strickland Ricketts
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations for the treatment of hormonal, genetic and endocrine disorders and conditions; pharmaceuticals for human use for the treatment of rare and orphan diseases, disorders and conditions; pharmaceutical preparations for the treatment of congenital adrenal hyperplasia
Owner
- Neurocrine Biosciences, Inc., San Diego, CA, US
- Neurocrine Biosciences, Inc., San Diego, CA, US
- Neurocrine Biosciences, Inc., San Diego, CA, US
Prosecution history
- 27 May 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 27 May 2025 — REGISTERED-PRINCIPAL REGISTER
- 03 May 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 03 May 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 13 Apr 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 31 Jan 2025 — USE AMENDMENT FILED
- 13 Apr 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 20 Mar 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 20 Mar 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 20 Mar 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 31 Jan 2025 — TEAS STATEMENT OF USE RECEIVED
- 24 Jul 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Jul 2024 — SOU EXTENSION 3 GRANTED
- 24 Jul 2024 — SOU EXTENSION 3 FILED
- 24 Jul 2024 — SOU TEAS EXTENSION RECEIVED